A recent prospective and multicenter study has shown that EPA treatment led to a numerically lower risk of coronary vascular events, but did not reach statistical significance in patients with stable CAD, a low EPA/AA ratio (<0.4), and on statin therapy [ 19 ].
← all excerpts
Relationship Between Serum ω-3 Polyunsaturated Fatty Acid Concentration and Fatty Acid Fraction of Epicardial Adipose Tissue in Patients With Cardiovascular Disease.
1
—
—